2015 - Insights & Innovations Blog

  • The Cancer Genome Atlas: More Than a Large Collection of Data
    December 7, 2015, by Jean Claude Zenklusen, Ph.D.

    Though TCGA will wrap up in 2016 with a concluding symposium, cancer genomics projects built upon the success of TCGA will continue to play a major part in the NCI’s mission to better understand and treat cancer in the years to come.

    Continue Reading >

  • Cancer Informatics: Expanding Access to Cancer Genomics Data
    December 2, 2015, by Amy E Blum, M.A.

    Drs. Staudt and Kibbe discuss the NCI’s major initiatives to improve both the accessibility and usability of cancer genomics data. Top among the NCI’s priorities are the Genomic Data Commons, a service that will bring together and harmonize cancer genomic data sets from NCI programs and non-NCI data submitters, and the Cancer Genomics Cloud Pilots.

    Continue Reading >

  • Researcher Interview: Matthew Meyerson
    November 6, 2015, by Amy E Blum, M.A.

    In this interview, Matthew Meyerson, M.D., Ph.D., Professor of Pathology at Dana-Farber Cancer Institute and Harvard Medical School, talks about the clinical impact of his research on lung cancer and discusses developing technologies and ongoing challenges in the field of cancer genomics.

    Continue Reading >

  • Funding Opportunity: Genomic Data Analysis Network Centers
    October 29, 2015, by Amy Blum, M.A.

    The National Cancer Institute (NCI) has published three companion Funding Opportunity Announcements (FOAs) for Genomic Data Analysis Network Centers to support programs of the Center for Cancer Genomics (CCG). The FOAs are managed by CCG and solicit applications for a Processing Genomic Data Center, a Visualization Genomic Data Center, and a Specialized Genomic Data Center.

    Continue Reading >

  • Study Identifies Biomarker that Detects Early Pancreatic Cancer
    September 15, 2015, by Amy E Blum, M.A.

    Researchers from the University of Texas MD Anderson Cancer Center have identified a protein marker that is found at much higher levels in exosomes that derive from cancer cells compared to healthy cells, a discovery that may improve the detection and treatment of pancreatic cancer.

    Continue Reading >

Featured Posts